ABP 501 (adalimumab-atto) in the treatment of inflammatory bowel disease: An example of evidence-based extrapolation

  1. Núñez, F.M.
  2. Taxonera, C.
  3. Marrón, J.
Revue:
Revista Espanola de Enfermedades Digestivas

ISSN: 1130-0108

Année de publication: 2021

Volumen: 113

Número: 10

Pages: 737

Type: Lettre

DOI: 10.17235/REED.2021.7921/2021 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus